Can't find Amphotericin B? Learn about alternative antifungal medications like Voriconazole, Caspofungin, and Fluconazole that your doctor may consider.
Being prescribed Amphotericin B means you're dealing with a serious fungal infection — and finding out that your medication is unavailable adds a layer of stress you don't need. The ongoing Amphotericin B shortage has left many patients and providers scrambling for alternatives.
The good news is that the antifungal medication landscape has expanded significantly over the past two decades. While Amphotericin B remains the gold standard for certain infections, newer drugs may work just as well — or even better — for your specific condition, with fewer side effects.
In this article, we'll explain what Amphotericin B does, how it works, and walk through the most commonly prescribed alternatives.
Amphotericin B is a polyene antifungal medication that has been used since the 1950s to treat life-threatening fungal infections. Brand names include Fungizone (conventional), AmBisome (liposomal), and Abelcet (lipid complex).
It's used to treat conditions such as:
For a complete overview, see our article on what Amphotericin B is, its uses, and dosage.
Amphotericin B works by binding to ergosterol, a key component of the fungal cell membrane. This binding creates pores (holes) in the membrane, causing essential ions to leak out and ultimately killing the fungal cell.
This mechanism gives Amphotericin B a broad spectrum of activity against many types of fungi, which is why it's been a cornerstone of antifungal therapy for decades. However, it also interacts with cholesterol in human cell membranes, which is what causes many of its side effects — particularly kidney damage.
For more details on how this drug works, check out our article on Amphotericin B's mechanism of action.
The right alternative depends entirely on the type of fungal infection you have, how severe it is, and your overall health. Never switch medications on your own — always work with your infectious disease specialist or prescribing doctor. Here are the most commonly considered alternatives.
Drug class: Triazole antifungal
Best for: Invasive aspergillosis (now the preferred first-line treatment), certain Candida infections, some rare mold infections
Voriconazole has become the go-to first-line treatment for invasive aspergillosis, replacing Amphotericin B as the preferred option based on clinical trials showing better outcomes and fewer severe side effects. A landmark study published in the New England Journal of Medicine found that patients treated with Voriconazole had better survival rates than those treated with Amphotericin B.
How it's different:
Limitations: Not effective against mucormycosis. Has significant drug interactions with many medications.
Drug class: Echinocandin antifungal
Best for: Invasive candidiasis, empirical antifungal therapy in neutropenic patients, salvage therapy for aspergillosis
Caspofungin belongs to the echinocandin class, which works differently from both Amphotericin B and the azoles. It inhibits the synthesis of beta-glucan, a component of the fungal cell wall (not the membrane). This makes it effective against Candida and Aspergillus species with a much better safety profile than Amphotericin B.
How it's different:
Limitations: Not effective against Cryptococcus or mucormycosis. IV-only administration.
Drug class: Triazole antifungal
Best for: Many Candida infections, cryptococcal meningitis (maintenance/consolidation therapy), coccidioidomycosis
Fluconazole is one of the most widely used antifungal medications in the world. It's much easier to tolerate than Amphotericin B and is available in both oral and IV forms, making it a practical choice for long-term treatment.
How it's different:
Limitations: Narrower spectrum — not effective against Aspergillus, mucormycosis, or many non-albicans Candida species. Not appropriate for the most severe acute infections where Amphotericin B is typically used.
Drug class: Echinocandin antifungal
Best for: Invasive candidiasis, prophylaxis in stem cell transplant patients, esophageal candidiasis
Like Caspofungin, Micafungin is an echinocandin that targets the fungal cell wall. It has a favorable safety profile and relatively few drug interactions compared to both Amphotericin B and the azoles.
How it's different:
Limitations: Not effective against Cryptococcus or mucormycosis. Limited to IV administration.
This is where alternatives become more limited. For mucormycosis (zygomycosis), Amphotericin B — particularly the liposomal formulation (AmBisome) — remains the preferred first-line treatment. None of the echinocandins or standard azoles are effective against this infection.
If you need treatment for mucormycosis and the conventional form is unavailable:
Be sure to discuss these options with your infectious disease doctor.
The choice of alternative depends on several factors:
Your infectious disease specialist will weigh all of these factors when choosing the best medication for you.
While Amphotericin B remains irreplaceable for certain infections, modern antifungal medicine offers several effective alternatives for many conditions. If you're unable to access Amphotericin B due to the current shortage, work closely with your medical team to identify the best alternative for your specific situation.
If you're still trying to locate Amphotericin B, check out our guide on how to find it in stock near you or use Medfinder to search for real-time availability.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
